Inhabitants well being know-how firm Colour Well being introduced the appointment of Dr. Rebecca Miksad as chief medical officer and Josh Sturm as chief income officer.
Miksad is a medical oncologist and head of Boston College College of Drugs’s Excessive Threat Most cancers Genetics Clinic and previously held the place of senior medical director at oncology-focused digital well being firm Flatiron Well being.
She is going to oversee Colour’s medical and scientific elements, together with the event of its Digital Most cancers Clinic.
Sturm will concentrate on increasing Colour’s partnerships. He previously served as vice chairman at digital musculoskeletal firm Hinge Well being. He was additionally the vice chairman at Surescripts and Cigna-owned on-line pharmacy and pharmacy profit supervisor Categorical Scripts.
“Josh and Rebecca have very important on-the-ground expertise in affected person and buyer relationships which can be invaluable in telling the story of what working with an organization like Colour can do for each corporations and particular person sufferers,” Othman Laraki, CEO of Colour Well being, stated in a press release.
“Their experience personifies Colour’s work, taking particular person connections and scaling them into well being advantages that attain 1000’s of individuals, and units us as much as proceed increasing the attain and high quality of our companies for our clients.”
Digital cardiac and lung-disease well being startup Eko Well being is including Brent D. Lang to its board of administrators.
Lang is a former Olympic gold medalist and was chairman and CEO of Vocera Communications. He led Vocera by means of its development, IPO and $3 billion acquisition by Stryker.
“Brent’s wealth of expertise in healthcare know-how and firm constructing, mixed with a deep dedication to bettering affected person outcomes, makes him the right companion for Eko as we proceed to assist clinicians diagnose cardiopulmonary illnesses earlier and with better accuracy,” Connor Landgraf, CEO of Eko Well being, stated in a press release. “We’re thrilled to welcome him to our Board.”
Healthcare know-how firm Medtronic has employed Dr. James Porter as chief medical officer of robotic surgical applied sciences and digital applied sciences throughout the surgical enterprise, which is a part of the corporate’s Medical Surgical Portfolio.
Porter is a practising urologic surgeon specializing in prostate, kidney most cancers and urinary constructive procedures. The corporate says he’s “a acknowledged chief among the many international surgical neighborhood and one of many high 5 robotic surgical procedure practitioners within the U.S.”
He’s additionally the medical director of robotic surgical procedure at Windfall Swedish in Seattle, Washington.
“Medtronic is privileged to welcome such a famend doctor to our enterprise, and we look ahead to Dr. Porter’s contributions as CMO of our robotic and digital divisions as we execute our technique to scale and regularly advance our capabilities to satisfy buyer wants and positively impression sufferers world wide,” Rajit Kamal, normal supervisor and vice chairman of Robotic Surgical Applied sciences throughout the surgical enterprise at Medtronic, stated in a press release.”
